2864 Organometallics, Vol. 22, No. 14, 2003
Plourde et al.
(M+). Anal. Calcd for C44H58O6P2: C, 70.95; H, 7.79. Found:
C, 69.84; H, 8.09.
COD), 1.85 (br m, 8H, CH2CH3), 1.15-1.4 (br m, 12H, P(CH3)2),
1.11 (t, 6H, J ) 7.37, CH2CH3), 0.86 (t, 6H, J ) 7.51, CH2CH3);
31P{1H} NMR (CD2Cl2) -6.71 (d, Pcalix, J P-Rh ) 144), -141.13
(sept, PF6-, J P-F ) 710); MS (MALDI-TOF) 815 (100%,
(CalixP2)Rh), 923 (30%, (CalixP2)Rh(COD)), 1560 (5%, (CalixP-
(O)P)]2Rh), 1771 (10%, (CalixP2)Rh2PF6). Anal. Calcd for
C52H70O4F6P3Rh: C, 58.43; H, 6.60. Found: C, 58.35; H, 6.59.
5,17-Bis(d iisop r op ylp h osp h in oyl)-25,26,27,28-tetr a -n -
p r op oxyca lix[4]a r en e (4b) (Con e). This compound was
prepared according to the same procedure described for 4a
using i-Pr2PCl as phosphinating agent. A white solid was
obtained. Yield: 55%; Tm ) 222-225 °C; IR (neat solid): ν(Pd
O) ) 1206 cm-1; 1H NMR (CD2Cl2) 7.66 (d, 4H, J ) 12.00, Ph),
6.20 (t, 2H, J ) 7.62, Ph), 5.96 (d, 4H, J ) 7.64, Ph), 4.49 (d,
4H, J ) 13.60, ArCH2), 4.18 (t, 4H, J ) 8.10, OCH2), 3.65 (t,
4H, J ) 6.72, OCH2), 3.31 (d, 4H, 13.69, ArCH2), 3.05 (m, 4H,
PCH(CH3)2), 1.90 (m, 8H, CH2CH3), 1.53 (d, 6H, J ) 7.00, PCH-
(CH3)2), 1.47 (d, 6H, J ) 7.03, PCH(CH3)2), 1.40 (d, 6H, J )
7.12, PCH(CH3)2), 1.34 (d, 6H, J ) 7.12, PCH(CH3)2), 1.08 (t,
6H, J ) 7.20, CH2CH3), 0.89 (t, 6H, J ) 7.40, CH2CH3); 13C-
Bis[µ-bis(5,17-bis(d iisop r op ylp h osp h in o))-25,26,27,28-
tetr a -n -p r op oxyca lix[4]a r en e)(1,5-cycloocta d ien e)r h od -
iu m (I)] Hexa flu or op h osp h a te (6b). This compound was
prepared according to the same procedure as described for 6a
using 5b diphosphine as starting material. An orange solid
was obtained in 90% yield (51.4 mg): Tm > 160 °C (dec); IR
(neat solid) ν(PF6-) ) 838 cm-1; 1H NMR (acetone-d6) 7.39 (d,
4H, J ) 7.87, Ph), 6.09 (m, 6H, Ph), 5.25 (br m, 4H, dCH
COD), 4.48 (d, 4H, J ) 13.36, ArCH2), 4.12 (t, 4H, J ) 8.07,
OCH2), 3.67 (t, 4H, J ) 6.59, OCH2), 3.49 (br m, 4H, CH2 COD),
3.29 (d, 4H, J ) 13.41, ArCH2), 2.79 (sext, 4H, J ) 8.95,
PCH(CH3)2), 2.37 (br m, 4H, CH2 COD), 2.04-1.82 (m, 8H,
CH2CH3), 1.51 (d, 6H, J ) 7.06, PCH(CH3)2), 1.46 (d, 6H, J )
7.08, PCH(CH3)2), 1.31 (d, 6H, J ) 6.93, PCH(CH3)2), 1.26 (d,
6H, J ) 6.91, PCH(CH3)2), 1.13 (t, 6H, J ) 7.37, CH2CH3),
0.91 (t, 6H, J ) 7.42, CH2CH3); 31P{1H} NMR (acetone-d6)
43.98 (d, Pcalix, J P-Rh ) 149), -137.65 (sept, PF6-, J P-F ) 704);
MS (MALDI-TOF) 927 (100%, (CalixP2)Rh), 1069 (15%,
(CalixP2)Rh(COD)), 1175 (5%, (CalixP2)Rh2PF6, 1281 (15%,
(CalixP2)Rh2(COD)PF6). Anal. Calcd for C60H88O4F6P3Rh: C,
60.90; H, 7.50. Found: C, 60.49; H, 7.53.
{1H} NMR (CDCl3) 163.94, 155.08, 139.45 (d, J C-P ) 12.5, CAr
-
P), 134.81, 134.70, 131.77, 127.35, 122.46, 77.28, 77.00, 30.67,
23.29 (d, J C-P ) 16.1, (CH3)2CH-P), 20.97, 20.39, 17.32, 16.44,
10.75, 9.64; 31P{1H} NMR (CD2Cl2) 29.57 (s); MS (FAB) 857
(M+). Anal. Calcd for C52H74O6P2: C, 72.88; H, 8.64. Found:
C, 72.74; H, 8.73.
5,17-B is (d im e t h y lp h o s p h in o )-25,26,27,28-t e t r a -n -
p r op oxyca lix[4]a r en e (5a ) (Con e). A 40 mg (0.056 mmol)
sample of 4a was dissolved in 5 mL of toluene under an inert
atmosphere. The solution was refluxed, and 0.2 mL (1.62
mmol) of phenylsilane was added. The solution was stirred
and refluxed for 12 h. The solvent was then evaporated, and
the crude product was purified using column chromatography
under inert atmosphere using a 5:95 ethyl acetate/hexane
mixture (Rf ) 0.38). A white solid was obtained (41 mg).
Yield: 105%; Tm ) 204-206 °C; 1H NMR (CD2Cl2) 7.06 (d, 4H,
J ) 7.35, Ph), 6.26 (m, 6H, Ph), 4.43 (d, 4H, J ) 13.21, ArCH2),
3.97 (t, 4H, J ) 8.03, OCH2), 3.71 (t, 4H, J ) 7.02, OCH2),
3.15 (d, 4H, J ) 13.28, ArCH2), 1.93 (t of q (∼sext), 4H, J )
7.50, CH2CH3), 1.90 (t of q (∼sext), 4H, J ) 7.50, CH2CH3),
1.24 (d, 12H, J ) 2.65, P(CH3)2), 1.06 (t, 6H, J ) 7.43,
CH2CH3), 0.92 (t, 6H, J ) 7.47, CH2CH3); 13C{1H} NMR (CD2-
Cl2) 159.71, 157.49, 138.25 (d, J C-P ) 6.4, CAr-P), 135.49,
135.08, 132.94, 132.70, 129.43, 123.77, 78.87, 78.53, 32.78,
25.31, 25.00, 16.65 (d, J C-P ) 13.0, CH3-P), 12.38, 11.62, 2.64;
31P NMR (CD2Cl2) -44.50 (s); MS (EI) 712 (M+).
Bis[µ-bis(5,17-bis(d ip h en ylp h osp h in o))-11,23-d ibr om o-
25,26,27,28-tetr a -n -p r op oxyca lix[4]a r en e)(1,5-cycloocta -
d ien e)r h od iu m (I)] Hexa flu or op h osp h a te (6c). This com-
pound was prepared according to the same procedure as
described for 6a using the 5c diphosphine as starting material.
An orange solid was obtained in 95% yield: Tm > 160 °C (dec);
IR (neat solid) ν(PF6-) ) 837 cm-1; 1H NMR (acetone-d6) 7.4-
7.9 (m, 22H, Ph), 7.36 (d, 2H, J ) 12.0, Ph), 6.61 (s, 2H, PhBr),
4.48 (d, 4H, J ) 13.5, ArCH2), 4.0-4.25 (br m, 2H), 4.06 (t,
2H, J ) 7.5, OCH2), 3.83 (t, 2H, J ) 7.0, OCH2), 3.5-3.7 (br
m, 2H), 3.30 (d, 4H, J ) 13.5, ArCH2), 2.4-2.6 (br m, 2H),
1.8-2.2 (m, 8H, CH2CH3), 0.8-1.2 (m, 8H, CH3); 31P{1H} NMR
-
5,17-Bis(d iisop r op ylp h osp h in o)-25,26,27,28-t et r a -n -
p r op oxyca lix[4]a r en e (5b) (Con e). The reduction procedure
was the same as that used for 5a using 4b as starting material.
A white solid was obtained in quantitative yield (100%): Tm
(acetone-d6) 30.04 (d, Pcalix, J P-Rh ) 145), -137.62 (sept, PF6
,
J P-F ) 708); MS (MALDI-TOF) 1221 (100%, (CalixP2)Rh), 1345
(35%, (CalixP2)ORh(COD)), 2440 (1%, (CalixP2)2Rh2)), 2552
(1%, (CalixP2)2Rh2(COD)). Anal. Calcd for C72H76Br2O4F6P3-
Rh: C, 52.25; H, 4.63. Found: C, 52.19; H, 4.54.
1
) 135-136 °C; H NMR (CD2Cl2) 7.21 (d, 4H, J ) 6.68, Ph),
6.14 (t, 2H, J ) 7.49, Ph), 6.04 (d, 4H, J ) 7.35, Ph), 4.44 (d,
4H, J ) 13.28, ArCH2), 4.04 (t, 4H, J ) 8.25, OCH2), 3.65 (t,
4H, J ) 6.66, OCH2), 3.14 (d, 4H, 13.35, ArCH2), 2.12 (m, 4H,
PCH(CH3)2), 1.91 (m, 8H, CH2CH3), 1.11 (dd, 12H, J ) 6.96,
PCH(CH3)2), 1.10 (t, 6H, J ) 7.45, CH2CH3), 0.98 (dd, 12H, J
) 6.84, PCH(CH3)2), 0.89 (t, 6H, J ) 7.45, CH2CH3); 13C{1H}
NMR (CD2Cl2) 159.32, 155.57, 137.00 (d, J C-P ) 8.1, CAr-P),
135.72, 135.46, 127.62, 122.32, 77.41, 76.85, 31.28, 23.96, 23.67
(d, J C-P ) 14.8, (CH3)2CH-P), 20.48, 20.23, 19.24, 19.13, 11.10,
10.00; 31P{1H} NMR (CD2Cl2) 12.95 (s); MS (EI) 825 (M+).
Bis[µ-b is(5,17-b is(d im e t h ylp h osp h in o))-25,26,27,28-
tetr a -n -p r op oxyca lix[4]a r en e)(1,5-cycloocta d ien e)r h od -
iu m (I)] Hexa flu or op h osp h a te (6a ). A solution of TlPF6 (18.7
mg, 53.4 µmol) and [RhCl(COD)]2 (12.0 mg, 24.3 µmol) in 8
mL of dry THF was stirred for 1 h at room temperature. Then,
a solution of compound 5a (34.5 mg, 48.5 µmol) in THF was
slowly added dropwise (for 1 h) to the previous rhodium
solution. The solution was stirred for an additional 16 h. Then,
the solution was filtered, and the solvent was evaporated. An
orange solid was obtained in 90% yield (46.6 mg): Tm > 145
°C (dec); IR (neat solid) ν(PF6-) ) 837 cm-1; 1H NMR (CD2Cl2)
7.22 (d, 4H, J ) 7.39, Ph), 7.01 (t, 2H, J ) 7.36, Ph), 6.03 (br
m, 4H, Ph), 4.96 (br m, 4H, dCH COD), 4.45 (d, 4H, J ) 13.85,
ArCH2), 3.98 (t, 4H, J ) 6.11, OCH2), 3.66 (t, 4H, J ) 6.56,
OCH2), 3.17 (t, 4H, J ) 13.9, ArCH2), 2.37 (br m, 8H, CH2
5,11-Bis(d im e t h ylp h osp h in oyl)-25,26,27,28-t e t r a -n -
p r op oxyca lix[4]a r en e (8a ) (Con e). A solution of 100 mg
(0.13 mmol) of 7 in 5 mL of dry THF at -78 °C was treated
with a solution of 0.18 mL (0.30 mmol) of t-BuLi 1.7 M in
hexane. The solution was stirred for 1 h at -78 °C, and 0.1
mL (0.65 mmol) of Me2PCl was added. The solution was stirred
for an additional 20 h and was allowed to reach room
temperature. Then 0.1 mL (0.88 mmol) of hydrogen peroxide
(30% in water) was added, and the mixture was stirred for 1
h. The solvent was then evaporated, and the yellow residue
was purified using column chromatography under inert at-
mosphere using a 10:90 ethanol/CHCl3 mixture (Rf ) 0.21). A
white solid was obtained. Yield: 25%; Tm ) 110-112 °C; IR
(neat solid) ν(PdO) ) 1206 cm-1 1H NMR (CDCl3) 7.02 (d,
;
2H, J ) 11.77, Ph), 6.95 (d, 2H, J ) 11.76, Ph), 6.67-653 (m,
4H, Ph), 4.50 (d, 1H, J ) 13.48, ArCH2CH2), 4.46 (d, 2H, J )
13.08, CH2), 4.41 (d, 1H, J ) 12.83, CH2), 3.96-3.76 (m, 8H,
OCH2), 3.24 (d, 1H, J ) 10.35, CH2), 3.20 (d, 2H, J ) 13.68,
ArCH2), 3.15 (d, 1H, J ) 14.23, CH2), 1.92 (t of q, 8H, CH2-
CH3), 1.52 (d, 6H, J P-H ) 3.50, P(CH3)2), 1.47 (d, 6H, J P-H
)
3.48, P(CH3)2), 0.99 (m, 12H, CH2CH3); 13C{1H} NMR (CDCl3)
159.32, 156.42, 135.99 (d, J C-P ) 13.1, CAr-P), 135.11, 134.28,
129.98, 129.89, 129.25, 129.14, 128.31, 128.02, 122.48, 77.11,
77.00, 30.91, 23.16, 18.57, 17.47, 10.09; 31P{1H} NMR (CDCl3)